(NASDAQ: HYFT) Mindwalk Holdings's forecast annual revenue growth rate of 46.1% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.57%.
Mindwalk Holdings's revenue in 2026 is $11,112,857.On average, 5 Wall Street analysts forecast HYFT's revenue for 2027 to be $964,600,033, with the lowest HYFT revenue forecast at $851,463,893, and the highest HYFT revenue forecast at $1,083,948,851. On average, 4 Wall Street analysts forecast HYFT's revenue for 2028 to be $1,186,247,837, with the lowest HYFT revenue forecast at $1,107,818,614, and the highest HYFT revenue forecast at $1,255,334,687.
In 2029, HYFT is forecast to generate $1,618,846,428 in revenue, with the lowest revenue forecast at $1,540,136,934 and the highest revenue forecast at $1,682,841,685.